1stabirateroneacademicacceleratedadcsadjuvantadvancedanalysisandreaantibodyapcccapproachesapprovalascoasco24atezolizumabauaavelumabbasedbcgbelzutifanbiomarkerbiomarkersbispecificbladderbonecabocabozantinibcanarycancercancerscarcinomacareercellcheckmatechemochoueirichristmascisclassificationclearclinicalconferencecontact2cosmiccovidcrpcctdnacupcystectomydatadebatedevelopmentdirecteddiscussesdiscussingdiscussiondiseasedrugdrugsearlyeaueikcsemergencyenzaenzalutamideerdafitinibesmoevevpfdafgfrfinalfirstfrontfuturegalskygermgermanyguguidelineshifhighhighlightshistoryholidayhormoneiiiimmuneimpactineligibleinhibitioninhibitorinvasiveioipiipilimumabislandsjapankeynotekidneylegendslinelitesparklivemaintenancemattmcrpcmdmeetingmetastaticmibcmolecularmonthmrccmusclenashvilleneoadjuvantniagaranivonivolumabnmibcnovelodacolapariboncologyoperativeoraloverviewpaperpapillaryparpipatientspdpd1peacepembropembrolizumabperiperspectivepetphasepluspostpreviewprostateprostatectomypsmaqolradioligandsradiotherapyrccrecaprefractoryrenalresistanceresponseresultsresumenreviewrisingriskrolescoreseriessessionshortssparingspecialstampedestarstudiesstudysummarysunrisesurgerysurveillancesurvivaltalaprotalazoparibtestistherapytonitoripalimabtourtreatmenttrestrialtrialsucunresponsiveupdateuramigasuromigosliveuromigoslive24urothelialvegfvejigaworldyear